OKIXERO Trademark

Trademark Overview

On Friday, January 9, 2009, a trademark application was filed for OKIXERO with the United States Patent and Trademark Office. The USPTO has given the OKIXERO trademark a serial number of 79065024. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, January 10, 2019. This trademark is owned by sanofi-aventis. The OKIXERO trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products for cancer prevention and treatment
okixero

General Information

Serial Number79065024
Word MarkOKIXERO
Filing DateFriday, January 9, 2009
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, January 10, 2019
Registration Number3663942
Registration DateTuesday, August 4, 2009
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2009

Trademark Statements

Goods and ServicesPharmaceutical products for cancer prevention and treatment
Translation of Words in MarkThe wording "OKIXERO" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, March 11, 2016
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, August 2, 2019NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Friday, August 2, 2019DEATH OF INTERNATIONAL REGISTRATION
Friday, April 28, 2017TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, February 16, 2017GENERIC MADRID TRANSACTION SENT TO IB
Thursday, February 16, 2017GENERIC MADRID TRANSACTION CREATED
Friday, November 11, 2016TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, March 11, 2016CANCELLED SECTION 71
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Sunday, December 11, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Thursday, December 23, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, December 18, 2009FINAL DECISION TRANSACTION PROCESSED BY IB
Friday, November 20, 2009FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 20, 2009FINAL DISPOSITION PROCESSED
Thursday, November 5, 2009FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, August 4, 2009REGISTERED-PRINCIPAL REGISTER
Tuesday, May 19, 2009PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2009NOTICE OF PUBLICATION
Friday, April 17, 2009REFUSAL PROCESSED BY IB
Saturday, April 11, 2009LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, April 10, 2009APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 10, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, April 10, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 9, 2009TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 9, 2009ASSIGNED TO LIE
Thursday, April 9, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 30, 2009NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, March 30, 2009REFUSAL PROCESSED BY MPU
Sunday, March 29, 2009NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Saturday, March 28, 2009NON-FINAL ACTION WRITTEN
Tuesday, March 24, 2009ASSIGNED TO EXAMINER
Tuesday, March 10, 2009APPLICATION FILING RECEIPT MAILED
Friday, March 6, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, March 5, 2009SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

okixero treatment prevention cancer products pharmaceutical